Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom F Brouwer

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Revista Espanola De Cardiologia (English Ed.)|November 14, 2016
Should the Subcutaneous Implantable Defibrillator Be the First Choice for Primary Prevention of Sudden Cardiac Death?Reinoud E Knops, Tom F Brouwer
Circulation|December 20, 2018
Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry"Tom F Brouwer, Martin C Burke, Reinoud E Knops
Journal of Clinical Hypertension (Greenwich, Conn.)|November 1, 2019
Blood pressure lowering treatment and the Framingham score: Do not fear riskTom F Brouwer, Didier Collard, Bert-Jan H van den Born
Circulation|June 6, 2018
Response by Kalkman et al to Letter Regarding Article, "J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm"Deborah N Kalkman, Tom F Brouwer, Bert-Jan H van den Born
Circulation|August 9, 2015
Association Between Chest Compression Interruptions and Clinical Outcomes of Ventricular Fibrillation Out-of-Hospital Cardiac ArrestTom F Brouwer, Robert G Walker, Fred W Chapman, et al.
Pacing and Clinical Electrophysiology : PACE|August 27, 2015
Subcutaneous Implantable Cardioverter Defibrillator Lead Failure due to Twiddler SyndromeKirsten M Kooiman, Tom F Brouwer, Vokko P Van Halm, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling StudyE Kevin Heist, Andres Belalcazar, Wyatt Stahl, et al.
Journal of the American Heart Association|November 23, 2019
Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL StudiesTom F Brouwer, William Whang, Kenji Kuroki, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Algorithm-Based Screening May Improve Patient Selection for the Subcutaneous Implantable DefibrillatorTom F Brouwer, Kirsten M Kooiman, Louise R Olde Nordkamp, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes MellitusDidier Collard, Tom F Brouwer, Ron J G Peters, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Revista Espanola De Cardiologia (English Ed.)|November 14, 2016
Should the Subcutaneous Implantable Defibrillator Be the First Choice for Primary Prevention of Sudden Cardiac Death?Reinoud E Knops, Tom F Brouwer
Circulation|December 20, 2018
Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry"Tom F Brouwer, Martin C Burke, Reinoud E Knops
Journal of Clinical Hypertension (Greenwich, Conn.)|November 1, 2019
Blood pressure lowering treatment and the Framingham score: Do not fear riskTom F Brouwer, Didier Collard, Bert-Jan H van den Born
Circulation|June 6, 2018
Response by Kalkman et al to Letter Regarding Article, "J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm"Deborah N Kalkman, Tom F Brouwer, Bert-Jan H van den Born
Circulation|August 9, 2015
Association Between Chest Compression Interruptions and Clinical Outcomes of Ventricular Fibrillation Out-of-Hospital Cardiac ArrestTom F Brouwer, Robert G Walker, Fred W Chapman, et al.
Pacing and Clinical Electrophysiology : PACE|August 27, 2015
Subcutaneous Implantable Cardioverter Defibrillator Lead Failure due to Twiddler SyndromeKirsten M Kooiman, Tom F Brouwer, Vokko P Van Halm, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling StudyE Kevin Heist, Andres Belalcazar, Wyatt Stahl, et al.
Journal of the American Heart Association|November 23, 2019
Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL StudiesTom F Brouwer, William Whang, Kenji Kuroki, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Algorithm-Based Screening May Improve Patient Selection for the Subcutaneous Implantable DefibrillatorTom F Brouwer, Kirsten M Kooiman, Louise R Olde Nordkamp, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes MellitusDidier Collard, Tom F Brouwer, Ron J G Peters, et al.
Pageof 5